The exogenous model of psychotic experience induced by novel psychoactive substances: A clinical overview

The previous two decades have been marked by profound societal transformations, including ongoing developments in the illegal drug market and the emergence of numerous novel psychoactive substances. Nevertheless, a comprehensive understanding of the diverse clinical presentations of psychopathologic...

Full description

Saved in:
Bibliographic Details
Main Authors: Giovanni Martinotti (Author), Gilberto Di Petta (Author), Tommaso Piro (Author), Eleonora Chillemi (Author), Filippo Maria Ferro (Author)
Format: Book
Published: Elsevier, 2024-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d4fc8d0b9f0c4ded8ab76de8cc27d1a3
042 |a dc 
100 1 0 |a Giovanni Martinotti  |e author 
700 1 0 |a Gilberto Di Petta  |e author 
700 1 0 |a Tommaso Piro  |e author 
700 1 0 |a Eleonora Chillemi  |e author 
700 1 0 |a Filippo Maria Ferro  |e author 
245 0 0 |a The exogenous model of psychotic experience induced by novel psychoactive substances: A clinical overview 
260 |b Elsevier,   |c 2024-12-01T00:00:00Z. 
500 |a 2667-1182 
500 |a 10.1016/j.etdah.2023.100141 
520 |a The previous two decades have been marked by profound societal transformations, including ongoing developments in the illegal drug market and the emergence of numerous novel psychoactive substances. Nevertheless, a comprehensive understanding of the diverse clinical presentations of psychopathological conditions, particularly within the domain of psychotic symptoms, remains deficient. In this clinical overview, our aim is to provide a detailed analysis of the psychotic manifestations induced by various substances. Exogenous psychoses may present with visual hallucinations, delusional perceptions, and paranoid ideation, frequently accompanied by an ego-dystonic experience that deviate from an individual's customary self-identity. Variations in the presentation of symptoms are also influenced by the specific pharmacological pathways with which the substance interacts. Visual hallucinations characterized by vivid colours and associated with positive or negative emotional experiences are most frequently linked to the serotonergic pathway. Paranoid ideation and auditory hallucinations are primarily associated with the dopaminergic pathways. Dissociative responses, often characterized by feelings of derealization and somatopsychic depersonalization, are typically elicited through glutamatergic pathways. Lastly, the endocannabinoid pathways are associated with anxiety-related psychosis-like states, ideas of reference, grandiose delusions, and paranoid delusions. 
546 |a EN 
690 |a Substance induced psychosis 
690 |a Lysergic psychoma 
690 |a Exogenous psychosis 
690 |a Novel psychoactive substances 
690 |a Substance use disorder 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Emerging Trends in Drugs, Addictions, and Health, Vol 4, Iss , Pp 100141- (2024) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2667118223000922 
787 0 |n https://doaj.org/toc/2667-1182 
856 4 1 |u https://doaj.org/article/d4fc8d0b9f0c4ded8ab76de8cc27d1a3  |z Connect to this object online.